CELLINK and Nanoscribe join forces to launch the Quantum X bio, the world’s most accurate 3D bioprinter
The Quantum X bio combines CELLINK’s bioprinting expertise with the engineering excellence of Nanoscribe to create a first-of-Its-kind bioprinter Today, BICO companies CELLINK and Nanoscribe announced the launch of the Quantum X bio, a revolutionary printing platform providing researchers with first-of-its-kind submicron bioprinting resolution. Powered by Two Photon Polymerization (2PP), the Quantum X bio is the premier tool for miniaturizing bioprinting, redefining what it means to work within advanced biomedical applications, including tissue engineering and regenerative medicine.